OCT 09, 2019 12:00 PM PDT

What is New in Surgical Management of Invasive Bladder Cancer in 2020

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Surgeon, Dept of Urology, Chair, Dept of Urology, Director, Applied Technology Laboratory for Advanced Surgery, Robert P. Huben Endowed Professor of Oncology, Roswell Park Cancer Institute
    Biography
      Khurshid A. Guru, MD, was appointed Director of Robotic Surgery at Roswell Park Cancer Institute (RPCI) in October 2005 and Chair, Department of Urology in June 2017. Dr. Guru completed his residency training in Urologic Surgery (2005) and a Robotic Surgery Fellowship (2004), Henry Ford Health System, MI. He also completed an International Fellowship in Urologic-Oncology (2004) at the Urology and Nephrology Center at Mansoura University, Mansoura, Egypt. Dr. Guru is one of the early fellowship-trained robotic surgeons (2004) with an experience of over 10,000 surgical console hours and has performed over 2,500 procedures. Dr. Guru performed one of the first robot-assisted radical cystectomy in the world, and has worked in development and evolution of oncologic safety and efficacy of minimally invasive approaches to bladder cancer. Dr. Guru has performed live demonstrations of robotic surgery in eleven countries at international seminars. His experience in robot-assisted surgery, especially his 600 robot-assisted radical cystectomies, has been shared with over 400 surgeons from more than 15 countries. His research interest has also been in the application of robotic surgery for urinary reconstruction. Dr. Guru developed one of the first robotic surgical simulators and works extensively in safe human machine interface, cognitive interaction and developing safe environments during robot-assisted surgery. Dr. Guru developed the first validated robotic surgery curriculum for safe transfer of surgical skills for future robotic surgeons. His major interest is bladder cancer and robotic surgical education and its incorporation. He leads the International Robotic Cystectomy Consortium with over 55 surgeon members in over 23 countries. He also leads the Applied Technology Laboratory for Advanced Surgery (ATLAS) Program at RPCI.
      Dr. Guru is a member of the American Urological Association, Cancer Society of Kashmir. He founded a non-profit foundation in 2007 which supports health and education related programs in Kashmir. His foundation supports children in government run schools in his native home, Kashmir.
      He has authored and co-authored over 250 several journal articles, abstracts and book chapters.

    Abstract

    The introduction of robot-assisted surgical technology into urological practice, has introduced new horizons for reducing the morbidity and enhancing the efficacy of surgery. Open radical cystectomy was the gold standard however over the years robot-assisted radical cystectomy has proven improved perioperative morbidity and similar oncologic outcomes. We investigate the status of RARC in 2019

     


    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    Loading Comments...
    Show Resources
    Attendees
    • See more